Results 191 to 200 of about 11,305,394 (400)
PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer
Molecular Oncology, EarlyView.Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.Nicolas Gordon, Peter T. Gallagher, Orly I. Richter, Neermala Poudel Neupane, Amy C. Mandigo, Jennifer J. McCann, Emanuela Dylgjeri, Irina Vasilevskaya, Christopher McNair, Channing J. Paller, Wm. Kevin Kelly, Karen E. Knudsen, Matthew J. Schiewer, Ayesha A. Shafi +13 morewiley +1 more sourcePlecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin
Molecular Oncology, EarlyView.The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.Zuzana Outla, Jan Kosla, Magdalena Prechova, Lukas Frick, Patricia Bortel, Yasmin Borutzki, Andrea Bileck, Christopher Gerner, Samuel M. Meier‐Menches, Selma Osmanagic‐Myers, Martin Gregor +10 morewiley +1 more sourceIdentification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project
Nature, 2007 E. Birney, J. Stamatoyannopoulos, A. Dutta, R. Guigó, T. Gingeras, E. Margulies, Z. Weng, M. Snyder, E. Dermitzakis, R. Thurman, Michael S. Kuehn, Christopher M. Taylor, Shane J. Neph, Christoph M. Koch, S. Asthana, A. Malhotra, I. Adzhubei, J. Greenbaum, R. Andrews, Paul Flicek, Patrick J Boyle, Hua Cao, N. Carter, Gayle K. Clelland, S. Davis, Nathan Day, P. Dhami, Shane C. Dillon, M. Dorschner, H. Fiegler, P. Giresi, Jeff Goldy, M. Hawrylycz, Andrew K. Haydock, R. Humbert, K. James, Brett E. Johnson, Ericka M. Johnson, Tristan Frum, Elizabeth R. Rosenzweig, N. Karnani, K. Lee, Gregory Lefebvre, P. Navas, Fidencio V. Neri, Stephen C. J. Parker, P. Sabo, R. Sandstrom, A. Shafer, D. Vetrie, M. Weaver, S. Wilcox, Man Yu, F. Collins, J. Dekker, J. Lieb, T. Tullius, G. Crawford, S. Sunyaev, W. S. Noble, I. Dunham, F. Denoeud, A. Reymond, P. Kapranov, J. Rozowsky, D. Zheng, R. Castelo, A. Frankish, J. Harrow, Srinka Ghosh, A. Sandelin, I. Hofacker, R. Baertsch, Damian Keefe, S. Dike, Jill Cheng, H. Hirsch, E. Sekinger, Julien Lagarde, J. F. Abril, Atif Shahab, Christoph Flamm, C. Fried, J. Hackermüller, Jana Hertel, Manja Lindemeyer, Kristin Missal, Andrea Tanzer, Stefan Washietl, J. Korbel, O. Emanuelsson, J. S. Pedersen, Nancy E. Holroyd, Ruth Taylor, D. Swarbreck, N. Matthews, M. Dickson, D. Thomas, M. Weirauch, J. Gilbert, J. Drenkow, I. Bell, X. Zhao, K. Srinivasan, W. Sung, H. Ooi, K. Chiu, S. Foissac, T. Alioto, M. Brent, L. Pachter, M. Tress, A. Valencia, S. Choo, C. Choo, C. Ucla, C. Manzano, Carine Wyss, E. Cheung, T. Clark, James B. Brown, M. Ganesh, Sandeep Patel, H. Tammana, Jacqueline Chrast, Charlotte N. Henrichsen, C. Kai, J. Kawai, Ugrappa Nagalakshmi, Jiaqian Wu, Zheng Lian, Jin Lian, P. Newburger, Xueqing Zhang, P. Bickel, J. Mattick, Piero Carninci, Y. Hayashizaki, S. Weissman, T. Hubbard, R. M. Myers, J. Rogers, P. Stadler, T. Lowe, Chia-Lin Wei, Y. Ruan, K. Struhl, M. Gerstein, S. Antonarakis, Yutao Fu, E. Green, Ulas Karaöz, A. Siepel, James Taylor, L. Liefer, K. Wetterstrand, P. Good, E. Feingold, M. Guyer, G. Cooper, G. Asimenos, Colin N. Dewey, Minmei Hou, S. Nikolaev, J. Montoya-Burgos, A. Löytynoja, S. Whelan, F. Pardi, Tim Massingham, Haiyan Huang, Na Zhang, I. Holmes, Jim Mullikin, A. Ureta-Vidal, B. Paten, Michael R. Seringhaus, D. Church, K. Rosenbloom, W. Kent, Eric A. Stone, S. Batzoglou, N. Goldman, R. Hardison, D. Haussler, Webb Miller, A. Sidow, N. Trinklein, Zhengdong D. Zhang, Leah Barrera, R. Stuart, D. King, A. Ameur, Stefan Enroth, M. Bieda, Jonghwan Kim, A. Bhinge, N. Jiang, Jun Liu, Fei Yao, V. Vega, C. Lee, Patrick Ng, A. Yang, Z. Moqtaderi, Zhou Zhu, Xiaoqin Xu, S. Squazzo, M. Oberley, David Inman, Michael A. Singer, T. Richmond, Kyle J. Munn, Á. Rada-Iglesias, Ola Wallerman, J. Komorowski, J. Fowler, Phillippe Couttet, Alexander W. Bruce, O. Dovey, P. Ellis, C. Langford, D. Nix, G. Euskirchen, S. Hartman, A. Urban, P. Kraus, Sara Van Calcar, Nathaniel D. Heintzman, Tae Hoon Kim, Kun Wang, Chunxu Qu, G. Hon, R. Luna, C. Glass, M. Rosenfeld, S. Aldred, S. Cooper, Anason S. Halees, J. M. Lin, H. Shulha, Xiaoling Zhang, Mousheng Xu, Jaafar N. Haidar, Yon-Jong Yu, V. Iyer, Roland Green, C. Wadelius, P. Farnham, B. Ren, R. Harte, A. Hinrichs, Heather Trumbower, H. Clawson, Jennifer Hillman-Jackson, A. Zweig, Kayla E. Smith, Archana Thakkapallayil, G. Barber, R. Kuhn, D. Karolchik, L. Armengol, C. Bird, P. D. de Bakker, Andrew D. Kern, N. López-Bigas, Joel D Martin, B. Stranger, A. Woodroffe, Eugene Davydov, A. Dimas, E. Eyras, Ingileif B. Hallgrímsdóttir, J. Huppert, M. Zody, G. Abecasis, X. Estivill, G. Bouffard, Xiaobin Guan, Nancy F. Hansen, J. Idol, Valerie V B Maduro, Baishali Maskeri, Jennifer C Mcdowell, Morgan Park, Pamela J. Thomas, Alice C. Young, R. Blakesley, D. Muzny, E. Sodergren, D. Wheeler, K. Worley, Huaiyang Jiang, G. Weinstock, R. Gibbs, T. Graves, R. Fulton, E. Mardis, R. Wilson, M. Clamp, James A. Cuff, S. Gnerre, D. Jaffe, Jean L. Chang, K. Lindblad-Toh, E. Lander, M. Koriabine, M. Nefedov, K. Osoegawa, Y. Yoshinaga, B. Zhu, P. D. de Jong +310 moresemanticscholar +1 more sourcePhenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer
Molecular Oncology, EarlyView.Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer +9 morewiley +1 more sourceO03: Hydroxocobalamin (OHCbl) dose intensification can prevent visual deterioration and improve neurological and biochemical outcomes in CBLC deficiency
Genetics in Medicine OpenCharles Venditti, Jennifer Sloan, Wadih Zein, Audrey Thurm, Camryn Hall, Carol Van Ryzin, Susan Ferry, Abigael Gebremariam, Jennifer Myles, Laryssa Huryn, Brian Brooks, Irini Manoli +11 moredoaj +1 more source
